Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study
Authors
Keywords
Hepatitis C virus, Direct-acting antiviral, Depression, Sleep, Side effects
Journal
BMC Psychiatry
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1186/s12888-018-1735-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
- (2017) Omar Elsherif et al. PLoS One
- Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy
- (2016) D. Banerjee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection
- (2016) Mark S. Sulkowski et al. GASTROENTEROLOGY
- Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
- (2016) George N. Ioannou et al. GASTROENTEROLOGY
- HCV epidemiology in high-risk groups and the risk of reinfection
- (2016) Håvard Midgard et al. JOURNAL OF HEPATOLOGY
- Hepatitis C reinfection after sustained virological response
- (2016) Håvard Midgard et al. JOURNAL OF HEPATOLOGY
- Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients
- (2016) Damien C. Tully et al. LIVER INTERNATIONAL
- Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens
- (2015) Z. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Psychiatric Care During Hepatitis C Treatment: The Changing Role of Psychiatrists in the Era of Direct-Acting Antivirals
- (2015) Sanjeev Sockalingam et al. AMERICAN JOURNAL OF PSYCHIATRY
- The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B
- (2015) N. Coppola et al. CLINICAL MICROBIOLOGY AND INFECTION
- The safety of daclatasvir for the treatment of hepatitis C
- (2015) Syed-Mohammed Jafri et al. Expert Opinion On Drug Safety
- Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
- (2015) Francesco Negro et al. GASTROENTEROLOGY
- Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
- (2015) Barbara Rehermann et al. HEPATOLOGY
- Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Interferon-free, direct-acting antiviral therapy for chronic hepatitis C
- (2015) J. A. Gutierrez et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B virus burden in developing countries
- (2015) Rosa Zampino WORLD JOURNAL OF GASTROENTEROLOGY
- Factors influencing adherence in Hepatitis-C infected patients: a systematic review
- (2014) Tim Mathes et al. BMC INFECTIOUS DISEASES
- Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
- (2014) Carolina Hoyo-Becerra et al. BRAIN BEHAVIOR AND IMMUNITY
- Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
- (2014) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
- (2014) Claus Niederau et al. PLoS One
- An empirical study of alcohol consumption by patients considering HCV treatment
- (2014) Carol S. North et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
- (2013) Michael R. Kraus et al. HEPATOLOGY
- Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
- (2012) Martin Schaefer et al. JOURNAL OF HEPATOLOGY
- Agreement between physicians' and patients' ratings on the Montgomery–Åsberg Depression Rating Scale
- (2011) Janet L. Cunningham et al. JOURNAL OF AFFECTIVE DISORDERS
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition
- (2011) Valerie Byrnes et al. JOURNAL OF HEPATOLOGY
- Antiviral Completion Rates and Sustained Viral Response in Hepatitis C Patients With and Without Preexisting Major Depressive Disorder
- (2011) Peter Hauser et al. PSYCHOSOMATICS
- The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder
- (2009) Bruno Fantino et al. BMC Psychiatry
- A Review of Sleep Disturbance in Hepatitis C
- (2009) Sanjeev Sockalingam et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now